References
- 1. Analysis of the implementation of the activities for immunoprophylaxis in Bulgaria in 2018. Epidemiology Department, National Center for Infectious and parasitic disease, Sofia, Bulgaria.
- 2. European immunization week, 23-29 APRIL 2018, WHO, Communications package, Vaccineswork.
- 3. Weinberger B, Keller M, Putzer C et al. Protection against Tetanus and Diphtheria in Europe: The impact of age, gender and country of origin based on data from the MARK-AGE Study. Exp Gerontol. 2018; 105:109-112. doi: 10.1016/j. exger.2017.08.037.
- 4. Bayas JM, Vilella A, Bertran MJ et al. Immunogenicity and reactogenicity of the adult tetanus-diphtheria vaccine. How many doses are necessary? Epidemiol Infect 2001; 127:451-460.
- 5. Launay O, Toneatti C, Bernede C et al. Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendations. Hum Vaccin 2009; 5:341-346.
- 6. Kwetkat A, Lehmann T, Weinberger S, Schelling J. Analysis of vaccination data of patients aged 60 years and older from Bavaria and Thuringia. Z Gerontol Geriatr 2016; 49:126-131.
- 7. Kanitz EE, Wu LA, Giambi C. Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage. Vaccine 2012; 30:5222-5228.
- 8. Hainz U, Jenewein B, Asch E et al. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine 2005; 23:3232-3235.
- 9. Zasada A, Rastawicki W, Rokosz N, et al. Seroprevalence of diphtheria toxoid IgG antibodies in children, adolescents and adults in Poland. BMC Infect Dis 2013;13:551. doi: 10.1186/1471-2334-13-551.
- 10. Petráš M, Oleár V, Molitorisová M et al. Factors Influencing Persistence of Diphtheria Immunity and Immune Response to a Booster Dose in Healthy Slovak Adults. Vaccines (Basel). 2019; 7(4). pii: E139. doi: 10.3390/vaccines7040139.
- 11. Szczawinska-Poplonyk A, Breborowicz A, Samara H et al. Impaired antigen-specific immune response to vaccines in children with antibody production defects. Clin Vaccine Immunol 2015,22:875-882.doi:10.1128/CVI.00148-15.
- 12. World Health Organization. (2009). Immunological basis for immunization: module 2: diphtheria-update 2009, Update 2009. World Health Organization. https://apps.who.int/iris/handle/10665/44094
- 13. The immunological basis for immunization series: module 3: tetanus. Geneva: World Health Organization; 2018 (Immuno-logical basis for immunization series; module 3). Licence: CC BY-NC-SA 3.0 IGO.
- 14. Advisory Committee on Immunization Practices. Updated recommendations for use of tetanus toxoid, diphtheria toxoid and acellular pertussis vaccine from the Advisory Committee on Immunization Practices 2010. MMWR Morb Mortal Wkly Rep 2011; 60:13–15.
- 15. Paulke-Korinek M, Fischmeister G, Grac A et al. Peristence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines. Vaccine 2011; 29:5130-5136.
- 16. Gowin E, Wysockib J, Kaluzna E et al. Does vaccination ensure protection? Assessing diphtheria and tetanus antibody levels in a population of healthy children. A cross-sectional study. Medicine 2016; 95:49(e5571), dx.doi.org/10.1097/MD.0000000000005571.
- 17. Postfay-Barbe KM, Kobela M, Sottas C et al. Frequent failure of adolescent booster response to tetanus toxoid despite infant immunization: waning of infancy-induced immune memory? Vaccine 2010; 28:4356-4361. doi:10.1016/j.vaccine.2010.04.060.
- 18. Schauer U, Stemberg F, Rieger CH et al. Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults. Clin Diagn Lab Immunol. 2003; 10(2):202-207.
- 19. Edmunds WJ, Pebody RG, Aggerback H, et al. The seroepidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect 2000; 125:113–125.
- 20. Walory J, Grzesiowski P, Hryniewicz W. The prevalence of diphtheria immunity in healthy population in Poland. Epidemiol Infect 2001; 126:225-230.
- 21. Zarei S, Jeddi-Tehrani M, Akhondi MM et al. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response. Iran J Allergy Asthma Immunol 2009; 8:85-93.
- 22. Dorsey MJ, Orange JS. Impaired specific antibody response and increased B-cell population in transient hypogammaglobulinemia of infancy. Ann Allergy Asthma Immunol 2006; 97:590-595.
- 23. Orange JS, Ballow M, Stiehm ER et al. Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2012 Sep;130(3 Suppl):S1-24. doi: 10.1016/j.jaci.2012.07.002.